Clinical Trials · NCT00873223
Examination of the Effects of Liraglutide on the Mode of Action of Insulin Detemir
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 33
- Start date
- Mar 2009
- Locations
- 1 site, United States
- Primary endpoint
- Insulin detemir pharmacokinetics with and without liraglutide administration